Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice

British Journal of Pharmacology

Volumn 164, Issue 2, 2011, Pages 358-371

  Kagota, Satomi ^a   Chia, Elizabeth ^a   McGuire, John J ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

diabetes; endothelial dysfunction; nitric oxide; obesity; protease activated receptors; resistance arteries

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ACETYLCHOLINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; CYCLIC AMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IBERIOTOXIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 2; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MESENTERIC ARTERY; MOUSE; MUSCLE ISOMETRIC CONTRACTION; MYOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE TONE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINESTERASE; ALCOHOL OXIDOREDUCTASES; ANIMALS; ARTERIES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; GLYCOSURIA; MALE; MICE; MICE, INBRED C57BL; NITROPRUSSIDE; OBESITY; OLIGOPEPTIDES; PHENYLEPHRINE; POTASSIUM; RECEPTOR, PAR-2; RECEPTORS, LEPTIN; RNA, MESSENGER; VASODILATION;

EID: 80052019726     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01356.x     Document Type: Article

References (42)

1. Aman M, Hirano M, Kanaide H, Hirano K, (2010). Upregulation of proteinase-activated receptor-2 and increased response to trypsin in endothelial cells after exposure to oxidative stress in rat aortas. J Vasc Res 47: 494-506.
2. Belmadani S, Palen DI, Gonzalez-Villalobos RA, Boulares HA, Matrougui K, (2008). Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice. Diabetes 57: 1629-1637.
3. Cao J, Kitazawa T, Takehana K, Taneike T, (2006). Endogenous prostaglandins regulate spontaneous contractile activity of uterine strips isolated from non-pregnant pigs. Prostaglandins Other Lipid Mediat 81: 93-105. (Pubitemid 44666494)
4. Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, et al,. (1999). Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 99: 2590-2597. (Pubitemid 29228292)
5. Cosentino F, Luscher TF, (1998). Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32 (Suppl. 3): S54-S61. (Pubitemid 29019754)
6. Damiano BP, D'Andrea MR, de Garavilla L, Cheung WM, Andrade-Gordon P, (1999). Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb Haemost 81: 808-814. (Pubitemid 29216570)
7. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R, (2005). Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454. (Pubitemid 40396812)
8. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, et al,. (2005). COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735. (Pubitemid 41033368)
9. Hamilton JR, Frauman AG, Cocks TM, (2001). Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 89: 92-98. (Pubitemid 34135497)
10. Hansen KK, Oikonomopoulou K, Li Y, Hollenberg MD, (2008). Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems. Naunyn Schmiedebergs Arch Pharmacol 377: 377-392.
11. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ, (1998). Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 14: 241-249. (Pubitemid 28499613)
12. Ikeoka D, Pachler C, Korsatko S, Mader JK, Weinhandl H, Bodenlenz M, et al,. (2010). Interleukin-6 produced in subcutaneous adipose tissue is linked to blood pressure control in septic patients. Cytokine 50: 284-291.
13. Kagota S, Yamaguchi Y, Tanaka N, Kubota Y, Kobayashi K, Nejime N, et al,. (2006). Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 78: 1187-1196. (Pubitemid 43176713)
14. Kagota S, Fukushima K, Umetani K, Tada Y, Nejime N, Nakamura K, et al,. (2010). Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome. Clin Exp Pharmacol Physiol 37: 1035-1043.
15. Kennedy AJ, Ellacott KL, King VL, Hasty AH, (2010). Mouse models of the metabolic syndrome. Dis Model Mech 3: 156-166.
16. Levy J, Gavin JR, III, Sowers JR, (1994). Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 96: 260-273. (Pubitemid 24099226)
17. McGuire JJ, Dai J, Andrade-Gordon P, Triggle CR, Hollenberg MD, (2002a). Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2. J Pharmacol Exp Ther 303: 985-992. (Pubitemid 35424380)
18. McGuire JJ, Hollenberg MD, Andrade-Gordon P, Triggle CR, (2002b). Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br J Pharmacol 135: 155-169. (Pubitemid 34102109)
19. McGuire JJ, Hollenberg MD, Bennett BM, Triggle CR, (2004). Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2. Can J Physiol Pharmacol 82: 1103-1112. (Pubitemid 40343648)
20. McGuire JJ, Van Vliet BN, Gimenez J, King JC, Halfyard SJ, (2007). Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice. Pflugers Arch 454: 535-543. (Pubitemid 46872891)
21. Matsumoto T, Ishida K, Taguchi K, Kobayashi T, Kamata K, (2009). Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery. Peptides 30: 1729-1734.
22. Miike T, Kunishiro K, Kanda M, Azukizawa S, Kurahashi K, Shirahase H, (2008). Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice-possible dysfunction of receptor and/or receptor-G protein coupling. Naunyn Schmiedebergs Arch Pharmacol 377: 401-410.
23. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, et al,. (1997). Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272: 4043-4049. (Pubitemid 27078466)
24. Nacci C, Tarquinio M, De BL, Mauro A, Zigrino A, Carratu MR, et al,. (2009). Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology 150: 849-861.
25. Napoli C, de Nigris F, Wallace JL, Hollenberg MD, Tajana G, De Rosa G, et al,. (2004). Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol 57: 513-516. (Pubitemid 38621797)
26. Okon EB, Szado T, Laher I, McManus B, van Breemen C, (2003). Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530. (Pubitemid 38186462)
27. Pannirselvam M, Verma S, Anderson TJ, Triggle CR, (2002). Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136: 255-263. (Pubitemid 34587672)
28. Pannirselvam M, Ding H, Anderson TJ, Triggle CR, (2006). Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur J Pharmacol 551: 98-107. (Pubitemid 44648061)
29. Paoletti R, Bolego C, Poli A, Cignarella A, (2006). Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag 2: 145-152.
30. Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C, (2008). Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 295: H1982-H1988.
31. Pfaffl MW, Horgan GW, Dempfle L, (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
32. Ramachandran R, Hollenberg MD, (2008). Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153 (Suppl. 1): S263-S282. (Pubitemid 351340983)
33. Roviezzo F, Bucci M, Brancaleone V, Di LA, Geppetti P, Farneti S, et al,. (2005). Proteinase-activated receptor-2 mediates arterial vasodilation in diabetes. Arterioscler Thromb Vasc Biol 25: 2349-2354. (Pubitemid 41552653)
34. Russell JC, Proctor SD, (2006). Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc Pathol 15: 318-330. (Pubitemid 44755356)
35. Shaw DI, Hall WL, Williams CM, (2005). Metabolic syndrome: what is it and what are the implications? Proc Nutr Soc 64: 349-357. (Pubitemid 41160764)
36. Smeda JS, McGuire JJ, (2007). Effects of poststroke Losartan versus Captopril treatment on myogenic and endothelial function in the cerebrovasculature of SHRsp. Stroke 38: 1590-1596. (Pubitemid 46684179)
37. Smeda JS, McGuire JJ, Daneshtalab N, (2010). Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats. Peptides 31: 227-237.
38. Sobey CG, Cocks TM, (1998). Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke 29: 1439-1444. (Pubitemid 28300084)
39. Szerafin T, Erdei N, Fulop T, Pasztor ET, Edes I, Koller A, et al,. (2006). Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res 99: e12-e17. (Pubitemid 44337812)
40. Venkatapuram S, Shannon RP, (2006). Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome. Am J Ther 13: 64-71. (Pubitemid 43162450)
41. Yamada Y, Yamauchi D, Yokoo M, Ohinata K, Usui H, Yoshikawa M, (2008). A potent hypotensive peptide, novokinin, induces relaxation by AT2- and IP-receptor-dependent mechanism in the mesenteric artery from SHRs. Biosci Biotechnol Biochem 72: 257-259. (Pubitemid 351158972)
42. Zhang H, Zhang C, (2009). Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am J Biomed Sci 1: 133-142.